Literature DB >> 14504686

The mechanism of honokiol-induced and magnolol-induced inhibition on muscle contraction and Ca2+ mobilization in rat uterus.

Yu-Cheng Lu1, Hwei-Hsien Chen, Chien-Hsin Ko, Yi-Ruu Lin, Ming-Huan Chan.   

Abstract

The effects of honokiol and magnolol extracted from the Magnolia officinalis on muscular contractile responses and intracellular Ca(2+) mobilization were investigated in the non-pregnant rat uterus. Honokiol and magnolol (1-100 micromol/l) were observed to inhibit spontaneous and uterotonic agonists (carbachol, PGF(2alpha), and oxytocin)-, high K(+)-, and Ca(2+) channel activator (Bay K 8644)-induced uterine contractions in a concentration-dependent manner. The inhibition rate of honokiol on spontaneous contractions appeared to be slower than that of magnolol-induced response. The time periods that were required for honokiol and magnolol, at 100 micromol/l, to abolish 50% spontaneous contractions were approximately 6 min. Furthermore, honokiol and magnolol at 10 micromol/l also blocked the Ca(2+)-dependent oscillatory contractions. Consistently, the increases in intracellular Ca(2+) concentrations ([Ca(2+)](i)) induced by PGF(2alpha) and high K(+) were suppressed by both honokiol and magnolol at 10 micromol/l. After washout of these treatments, the rise in [Ca(2+)](i) induced by PGF(2alpha) and high K(+) was still partially abolished. In conclusion, the inhibitory effects of honokiol and magnolol on uterine contraction may be mediated by blockade of external Ca(2+) influx, leading to a decrease in [Ca(2+)](i). Honokiol and magnolol may be considered as putative Ca(2+) channel blockers and be of potential value in the treatment of gynecological dysfunctions associated with uterine muscular spasm and dysmenorrhea.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14504686     DOI: 10.1007/s00210-003-0802-8

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  26 in total

1.  The anxiolytic effect of two oriental herbal drugs in Japan attributed to honokiol from magnolia bark.

Authors:  H Kuribara; E Kishi; N Hattori; M Okada; Y Maruyama
Journal:  J Pharm Pharmacol       Date:  2000-11       Impact factor: 3.765

2.  Calcium-activated K+ channels as modulators of human myometrial contractile activity.

Authors:  K Anwer; C Oberti; G J Perez; N Perez-Reyes; J K McDougall; M Monga; B M Sanborn; E Stefani; L Toro
Journal:  Am J Physiol       Date:  1993-10

3.  Inhibition by magnolol of formylmethionyl-leucyl-phenyl alanine-induced respiratory burst in rat neutrophils.

Authors:  J P Wang; M F Hsu; S L Raung; L C Chang; L T Tsao; P L Lin; C C Chen
Journal:  J Pharm Pharmacol       Date:  1999-03       Impact factor: 3.765

4.  The mode of action of contractile effects induced by external calcium and its related bivalent cations in the KCl-depolarized rat uterus.

Authors:  M Kimura; I Kimura; M Maekawa
Journal:  Jpn J Pharmacol       Date:  1978-10

5.  Tocolysis with nifedipine or beta-adrenergic agonists: a meta-analysis.

Authors:  V Tsatsaris; D Papatsonis; F Goffinet; G Dekker; B Carbonne
Journal:  Obstet Gynecol       Date:  2001-05       Impact factor: 7.661

6.  Inhibition of smooth muscle contraction by magnolol and honokiol in porcine trachea.

Authors:  Chien-Hsin Ko; Hwei-Hsien Chen; Yi-Ruu Lin; Ming-Huan Chan
Journal:  Planta Med       Date:  2003-06       Impact factor: 3.352

7.  Anti-inflammatory and analgesic effects of magnolol.

Authors:  J P Wang; M F Hsu; S L Raung; C C Chen; J S Kuo; C M Teng
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-12       Impact factor: 3.000

8.  The spasmogenic action of potassium chloride in guinea-pig trachealis.

Authors:  R W Foster; R C Small; A H Weston
Journal:  Br J Pharmacol       Date:  1983-11       Impact factor: 8.739

Review 9.  Pathophysiology of dysmenorrhea.

Authors:  M Akerlund
Journal:  Acta Obstet Gynecol Scand Suppl       Date:  1979

10.  Modulatory effects of magnolol on potassium-stimulated 5-hydroxytryptamine release from rat cortical and hippocampal slices.

Authors:  T H Tsai; T F Lee; C F Chen; L C Wang
Journal:  Neurosci Lett       Date:  1995-02-15       Impact factor: 3.046

View more
  8 in total

Review 1.  Biological activity and toxicity of the Chinese herb Magnolia officinalis Rehder & E. Wilson (Houpo) and its constituents.

Authors:  Mélanie Poivre; Pierre Duez
Journal:  J Zhejiang Univ Sci B       Date:  2017 Mar.       Impact factor: 3.066

2.  Pharmacokinetic and Metabolic Profiling of Key Active Components of Dietary Supplement Magnolia officinalis Extract for Prevention against Oral Carcinoma.

Authors:  Dinh Bui; Li Li; Taijun Yin; Xinli Wang; Song Gao; Ming You; Rashim Singh; Ming Hu
Journal:  J Agric Food Chem       Date:  2020-06-04       Impact factor: 5.279

3.  Magnolol inhibits tumor necrosis factor-α-induced ICAM-1 expression via suppressing NF-κB and MAPK signaling pathways in human lung epithelial cells.

Authors:  Wu Chunlian; Wang Heyong; Xu Jia; Huang Jie; Chen Xi; Liu Gentao
Journal:  Inflammation       Date:  2014-12       Impact factor: 4.092

4.  Honokiol blocks store operated calcium entry in CHO cells expressing the M3 muscarinic receptor: honokiol and muscarinic signaling.

Authors:  Hsiu-Jen Wang; Alexis G Martin; Po-Kuan Chao; Rhett A Reichard; Adam L Martin; Yue-wern Huang; Ming-Huan Chan; Robert S Aronstam
Journal:  J Biomed Sci       Date:  2013-02-23       Impact factor: 8.410

5.  Honokiol, a constituent of Magnolia species, inhibits adrenergic contraction of human prostate strips and induces stromal cell death.

Authors:  Daniel Herrmann; Andrea Schreiber; Anna Ciotkowska; Frank Strittmatter; Raphaela Waidelich; Christian G Stief; Christian Gratzke; Martin Hennenberg
Journal:  Prostate Int       Date:  2014-08-26

6.  Cardiovascular protection of magnolol: cell-type specificity and dose-related effects.

Authors:  Jennifer Hui-Chun Ho; Chuang-Ye Hong
Journal:  J Biomed Sci       Date:  2012-07-31       Impact factor: 8.410

7.  Magnolia polyphenols attenuate oxidative and inflammatory responses in neurons and microglial cells.

Authors:  Dennis Y Chuang; Ming-Huan Chan; Yijia Zong; Wenwen Sheng; Yan He; Jing Hua Jiang; Agnes Simonyi; Zezong Gu; Kevin L Fritsche; Jiankun Cui; James C Lee; William R Folk; Dennis B Lubahn; Albert Y Sun; Grace Y Sun
Journal:  J Neuroinflammation       Date:  2013-01-29       Impact factor: 8.322

Review 8.  Autophagy as a Therapeutic Target of Natural Products Enhancing Embryo Implantation.

Authors:  Hyerin Park; Minkyoung Cho; Yoonju Do; Jang-Kyung Park; Sung-Jin Bae; Jongkil Joo; Ki-Tae Ha
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.